Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Sep 6;13:944898. doi: 10.3389/fimmu.2022.944898

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Huang, Sun, Hou, Liu and Wu

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The correlation between ARPC5 expression and clinical stage, histologic grade, and tumor molecular subtypes in various cancers based on Spearman’s correlation analysis (the correlation with p < 0.05 were displayed). (A) The correlation between ARPC5 expression and clinical stage in pan-cancer. (B–C) The expression levels of ARPC5 in different clinical stages of KIRC (B) and KIRP (C). (D) The correlation between ARPC2 expression and histologic grade in pan-cancer. (E–H) The expression levels of ARPC5 in different histologic grades of KIRC (E), LGG (F), LIHC (G), and UCEC (H). (I–R) The correlation between ARPC5 expression and molecular subtypes in ACC (I), BRCA (J), LGG (K), HNSC (L), KIRP (M), OV (N), LUSC (O), PCPG (P), STAD (Q), UCEC (R). rho; rank coefficient of Spearman. Pv; p-value. NS, no significance.